We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




US Laboratories Surveyed for Malaria Diagnosis

By LabMedica International staff writers
Posted on 06 Jan 2011
The accuracy of laboratories in detecting and identifying malaria parasites and assessing malaria screening practices has been evaluated.

The American Proficiency Institute (API; Traverse City, MI, USA) has examined the diagnostic precision of laboratories in the US to identify different species of malaria parasites and assessed whether the correct follow-up procedures were practiced. More...


Malaria is usually diagnosed in the laboratory by microscopic examination of a stained thick and thin blood smear or by the use of a rapid diagnostic test (RDT). Malaria RDTs detect specific antigens (proteins) produced by malaria parasites, that are present in the blood of infected or recently infected individuals. Some RDTs can detect only one species of the malaria parasite, Plasmodium falciparum, while some also detect other species of the parasite, P. vivax, P. malariae and P. ovale. Blood for these tests are commonly obtained from a finger-prick.

API reviewed proficiency-testing data from 1999 to 2008 to determine the rates of unacceptable responses for detecting and identifying Plasmodium species, the parasites that cause malaria. Laboratories in the United States were better able to detect and identify P. falciparum than other types of parasite species. However, when assessing malaria screening practices among current proficiency testing providers, the review found that half of the surveyed laboratories failed to offer a complete diagnostic workup, 25.0% failed to screen both thick and thin slides, and 36.1% failed to issue a final report within 24 hours.

The US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) estimates that approximately 1,500 cases of imported malaria are diagnosed each year in the US. Of these, 71% were acquired in Africa and about 41% were due to P. falciparum. In December 2010, an autochthonous case of P. falciparum malaria was diagnosed in a 31-year-old female resident of Jacksonville (FL, USA) who had no history of international travel.

Daniel C. Edson, M.S., M.T. (ASCP), API president and lead author of the report, said, "Malaria is a serious, sometimes fatal, disease and laboratories should be better prepared to identify various species of malaria parasites, the more rapidly patients may be treated and hopefully cured". The study was published in December 2010, in Lab Medicine.

Related Links:

American Proficiency Institute
CDC




New
Gold Member
Hematology Analyzer
Medonic M32B
Serological Pipet Controller
PIPETBOY GENIUS
New
Clinical Chemistry System
P780
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.